Tune Therapeutics, Inc.
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Holding
- Established
- 2020-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.tunetx.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
Phase 1
Recruiting
- Conditions
- Chronic Hep BChronic Hepatitis bChronic HepatitisHBV
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2025-09-09
- Lead Sponsor
- Tune Therapeutics, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT06671093
- Locations
- π²π©
PMSI Republican Clinical Hospital "Timofei Mosneaga", Arensia Exploratory Medicine Phase I Unit, Chisinau, Moldova
ππ°Queen Mary Hospital, University of Hong Kong, Hong Kong, Hong Kong
π³πΏNew Zealand Clinical Research, Auckland, New Zealand
News
No news found